vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Rimini Street, Inc. (RMNI). Click either name above to swap in a different company.
Rimini Street, Inc. is the larger business by last-quarter revenue ($105.5M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). Rimini Street, Inc. runs the higher net margin — 1.3% vs -70.9%, a 72.2% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 1.2%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 1.1%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Rimini Street, Inc. is a global provider of independent third-party support services for enterprise software products including Oracle and SAP platforms. It serves clients across multiple industries worldwide, delivering cost-effective support, maintenance, and consulting solutions that help businesses cut operational expenses while ensuring software performance and security.
CTKB vs RMNI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $105.5M |
| Net Profit | $-44.1M | $1.4M |
| Gross Margin | 52.9% | 59.0% |
| Operating Margin | -9.0% | 4.6% |
| Net Margin | -70.9% | 1.3% |
| Revenue YoY | 8.1% | 1.2% |
| Net Profit YoY | -557.1% | -59.4% |
| EPS (diluted) | — | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $105.5M | ||
| Q4 25 | $62.1M | $109.8M | ||
| Q3 25 | $52.3M | $103.4M | ||
| Q2 25 | $45.6M | $104.1M | ||
| Q1 25 | $41.5M | $104.2M | ||
| Q4 24 | $57.5M | $114.2M | ||
| Q3 24 | $51.5M | $104.7M | ||
| Q2 24 | $46.6M | $103.1M |
| Q1 26 | — | $1.4M | ||
| Q4 25 | $-44.1M | $724.0K | ||
| Q3 25 | $-5.5M | $2.8M | ||
| Q2 25 | $-5.6M | $30.3M | ||
| Q1 25 | $-11.4M | $3.4M | ||
| Q4 24 | $9.6M | $6.7M | ||
| Q3 24 | $941.0K | $-43.1M | ||
| Q2 24 | $-10.4M | $-1.1M |
| Q1 26 | — | 59.0% | ||
| Q4 25 | 52.9% | 60.4% | ||
| Q3 25 | 52.7% | 59.9% | ||
| Q2 25 | 52.3% | 60.4% | ||
| Q1 25 | 48.6% | 61.0% | ||
| Q4 24 | 58.5% | 63.7% | ||
| Q3 24 | 56.3% | 60.7% | ||
| Q2 24 | 54.6% | 59.1% |
| Q1 26 | — | 4.6% | ||
| Q4 25 | -9.0% | 4.5% | ||
| Q3 25 | -17.6% | 4.2% | ||
| Q2 25 | -23.3% | 39.6% | ||
| Q1 25 | -36.1% | 9.0% | ||
| Q4 24 | 5.2% | 13.0% | ||
| Q3 24 | -8.2% | -47.4% | ||
| Q2 24 | -18.3% | -0.8% |
| Q1 26 | — | 1.3% | ||
| Q4 25 | -70.9% | 0.7% | ||
| Q3 25 | -10.5% | 2.7% | ||
| Q2 25 | -12.2% | 29.1% | ||
| Q1 25 | -27.5% | 3.2% | ||
| Q4 24 | 16.8% | 5.8% | ||
| Q3 24 | 1.8% | -41.2% | ||
| Q2 24 | -22.4% | -1.1% |
| Q1 26 | — | $0.01 | ||
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.32 | ||
| Q1 25 | — | $0.04 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | — | $-0.47 | ||
| Q2 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $132.2M |
| Total DebtLower is stronger | — | $56.4M |
| Stockholders' EquityBook value | $341.7M | — |
| Total Assets | $461.5M | $397.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $132.2M | ||
| Q4 25 | $90.9M | $120.0M | ||
| Q3 25 | $93.3M | $108.7M | ||
| Q2 25 | $75.5M | $101.3M | ||
| Q1 25 | $95.3M | $122.6M | ||
| Q4 24 | $98.7M | $88.8M | ||
| Q3 24 | $162.3M | $119.5M | ||
| Q2 24 | $177.9M | $134.2M |
| Q1 26 | — | $56.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $341.7M | $-27.0M | ||
| Q3 25 | $378.6M | $-27.3M | ||
| Q2 25 | $377.6M | $-29.0M | ||
| Q1 25 | $379.6M | $-63.7M | ||
| Q4 24 | $395.7M | $-69.4M | ||
| Q3 24 | $385.5M | $-76.8M | ||
| Q2 24 | $389.1M | $-36.1M |
| Q1 26 | — | $397.1M | ||
| Q4 25 | $461.5M | $423.1M | ||
| Q3 25 | $494.9M | $352.9M | ||
| Q2 25 | $493.3M | $397.5M | ||
| Q1 25 | $482.6M | $343.0M | ||
| Q4 24 | $499.5M | $369.1M | ||
| Q3 24 | $491.2M | $343.8M | ||
| Q2 24 | $483.7M | $367.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $19.6M | ||
| Q3 25 | $-3.9M | $24.7M | ||
| Q2 25 | $108.0K | $-17.8M | ||
| Q1 25 | $-125.0K | $33.7M | ||
| Q4 24 | $2.0M | $-37.7M | ||
| Q3 24 | $13.2M | $-18.5M | ||
| Q2 24 | $6.2M | $6.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $18.9M | ||
| Q3 25 | $-4.6M | $23.5M | ||
| Q2 25 | $-1.5M | $-19.5M | ||
| Q1 25 | $-974.0K | $32.8M | ||
| Q4 24 | $1.1M | $-38.4M | ||
| Q3 24 | $12.2M | $-19.2M | ||
| Q2 24 | $5.2M | $5.4M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 17.2% | ||
| Q3 25 | -8.7% | 22.7% | ||
| Q2 25 | -3.2% | -18.8% | ||
| Q1 25 | -2.3% | 31.5% | ||
| Q4 24 | 1.9% | -33.6% | ||
| Q3 24 | 23.7% | -18.3% | ||
| Q2 24 | 11.0% | 5.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 0.6% | ||
| Q3 25 | 1.3% | 1.2% | ||
| Q2 25 | 3.5% | 1.7% | ||
| Q1 25 | 2.0% | 0.9% | ||
| Q4 24 | 1.6% | 0.6% | ||
| Q3 24 | 2.0% | 0.6% | ||
| Q2 24 | 2.3% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.02× | ||
| Q3 25 | — | 8.94× | ||
| Q2 25 | — | -0.59× | ||
| Q1 25 | — | 10.06× | ||
| Q4 24 | 0.21× | -5.66× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RMNI
Segment breakdown not available.
